Drug intelligence / Profile preview

Calfar-Plus

Development stage: Unknown
Lead developer: Globus Remedies
Modality: Small Molecules
Administration: Oral

Overview

Calfar-Plus is a branded generic oral supplement manufactured by Globus Remedies, an Indian pharmaceutical company. It is a combination product containing **ferrous ascorbate**, **folic acid**, and **zinc sulphate**. Calfar-Plus is primarily indicated as a haematinic for the treatment and prevention of iron-deficiency anemia and associated nutritional deficiencies, particularly during pregnancy, lactation, and post-operative recovery. Ferrous ascorbate provides a highly bioavailable form of iron to support hemoglobin synthesis, while folic acid is essential for erythropoiesis and the prevention of neural tube defects. Zinc is included to support immune function and serve as a cofactor for numerous enzymatic processes.

Brand names: Calfar-Plus
Other names: Calfar Plus

Targets

DNA

Beyond the preview

Go deeper on Calfar-Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calfar-Plus.

Explore the full profile